Advertisement
Device Companies
Subscribe to Device Companies
View Sample

FREE Email Newsletter

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

May 22, 2014 2:19 pm | by Covidien | News | Comments

Covidien’s Stellarex drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial disease (PAD), according to new 24-month data released today from the company’s ILLUMENATE...

Preliminary Results from the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014 2:15 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation system provided safe and effective therapy for...

CoreValve System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

May 21, 2014 2:19 pm | by Medtronic Inc. | News | Comments

Medtronic, Inc. today revealed new data showing that patients treated with the CoreValve System experienced positive clinical outcomes in the rigorous "real world" Medtronic CoreValve ADVANCE Study. Presented at EuroPCR 2014, the transcatheter...

Advertisement

Strong Performance Data Reported for SYNERGY Stent System Trial

May 21, 2014 2:07 pm | by Boston Scientific | News | Comments

Boston Scientific Corporation reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the SYNERGY Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium (PtCr) Coronary Stent...

Lotus Valve System Demonstrates Strong Performance and Safety Profile at Six Months

May 21, 2014 1:56 pm | by Boston Scientific | News | Comments

Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corporation Lotus Valve System continued to demonstrate impressive performance at six months, according to new data presented...

Bringing Advanced Imaging to Patients via the Sea

May 21, 2014 12:07 pm | by GE | Videos | Comments

Dr. Keigo Yasukawa runs the Dr. GON clinic, which provides care to many elderly residents in Miyakojima island, population 54,000. The island sits some 200 miles due east of the northern tip of Taiwan and Yasukawa, who was born on Miyakojima...

3D Image Guidance Tool Sees, Reaches, and Treats Tumor Lesions

May 21, 2014 9:02 am | by Royal Philips | News | Comments

Royal Philips today announced the launch of EmboGuide, its latest innovation in interventional oncology, to treat difficult-to-reach tumors or tumors in patients who are deemed unsuitable for surgery. EmboGuide is a live 3D image guidance...

Medtronic Announces CE Mark and Launch of NC Euphora Coronary Balloon

May 20, 2014 10:26 am | by Medtronic | News | Comments

Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. has announced CE (Conformité Européene) mark and launch of the NC Euphora Noncompliant Balloon Dilatation Catheter...

Advertisement

Medtronic Settles Global Patent Litigation with Edwards Lifesciences

May 20, 2014 9:37 am | by Medtronic | News | Comments

Medtronic, Inc. announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation. Under the terms of the cross-license settlement agreement, the parties will dismiss all of the pending litigation matters...

First Implantation of Aesculap’s univation X Unicondylar Knee System

May 15, 2014 4:58 pm | by Aesculap Implant Systems LLC | News | Comments

Aesculap Implant Systems announced the implantation of the univation X Unidondylar Knee System on April 9, 2014. This case marks the first implantation for Aesculap’s univation X fixed knee implant worldwide and marked the limited launch...

Boston Scientific to Acquire Bayer’s Interventional Division for $415 Million

May 15, 2014 9:58 am | by Boston Scientific | News | Comments

In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in...

St. Jude Medical Announces First Implants in US Study of the Portico Transcatheter Aortic Heart Valve System

May 14, 2014 8:50 am | by St. Jude Medical Inc. | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial). The trial is evaluating the Portico...

Cardinal Health Completes Acquisition of AccessClosure

May 13, 2014 11:35 am | by Cardinal Health | News | Comments

Cardinal Health has announced the completion of the acquisition of AccessClosure, a leading manufacturer and distributor of extravascular closure devices in the United States. The $320 million acquisition was an all-cash transaction. "We're...

Advertisement

Pacemaker Algorithm Significantly Delays Atrial Fibrillation

May 12, 2014 9:48 am | by Medtronic Inc. | News | Comments

New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing feature exclusive to Medtronic, Inc. pacemakers significantly delays the progression of persistent...

Medtronic ICDs Safely Extend Detection Times for Secondary Prevention Patients

May 12, 2014 9:38 am | by Medtronic Inc. | News | Comments

Medtronic, Inc. today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary...

Study: Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

May 9, 2014 2:02 pm | by Medtronic | News | Comments

Medtronic, Inc. today released study findings that show heart failure patients who have limited options for implanted device therapy may benefit from a novel implant technique for cardiac resynchronization therapy (CRT) devices. Data from...

Leadless Pacemaker Showing Promising Results After One-Year

May 9, 2014 1:34 pm | by PR Newswire | News | Comments

Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising 12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional...

Common Test Used on Heart Patients Who Need Defibrillator Implants Unnecessary

May 9, 2014 12:05 pm | by McMaster University | News | Comments

New research from McMaster University suggests that a commonly performed test during certain types of heart surgery is not helpful and possibly harmful. The testing procedure, known as defibrillator testing (DT), is commonly used on people...

Boston Scientific Gets Heart Device Subpoena

May 9, 2014 11:05 am | by The Associated Press | News | Comments

Medical device maker Boston Scientific said Thursday the U.S. government wants documents related to its Cognis and Teligen heart devices. The company said in a regulatory filing that the U.S. Department of Health and Human Services wants...

Pacemaker and Defibrillator Patients Adhering to Remote Monitoring with St. Jude Medical's Merlin Technology Saw More than Double Survival Rate

May 8, 2014 6:13 pm | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, announced that data presented during a Late Breaking Clinical Trial Session during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found an association between...

Covidien Opens Advanced Medical Training and Research Center in Turkey

May 7, 2014 11:49 am | by Covidien | News | Comments

Further expanding its training and research capabilities in emerging markets, Covidien plc, has officially opened its Covidien Center of Innovation Turkey (CCI Turkey). Located in Istanbul, the new facility offers clinicians in Turkey and...

Boston Scientific to Acquire IoGyn Inc.

May 7, 2014 11:42 am | by Boston Scientific | News | Comments

Boston Scientific Corporation has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration...

Medtronic Agrees to Settle Certain INFUSE Bone Graft Product Liability Cases

May 6, 2014 11:11 am | by Medtronic | News | Comments

Medtronic Inc. has announced that it has agreed with certain plaintiffs' counsel to settle their inventories of filed and unfiled product liability claims related to INFUSE Bone Graft. Under the terms of the agreement, Medtronic has agreed...

Boston Scientific Joins Optum Labs as Founding Medical Device Partner

May 6, 2014 7:37 am | by PR Newswire | News | Comments

Boston Scientific Corporation has joined Optum Labs as the Founding Medical Device Partner to help pioneer new research into effective treatments for heart failure and related cardiac conditions. Optum Labs is an open collaborative healthcare...

MHIF Given the Chance at Its First Implant of World’s Smallest Cardiac Pacemaker

May 5, 2014 2:03 pm | by The Minneapolis Heart Institute Foundation (MHIF) | News | Comments

The Minneapolis Heart Institute Foundation (MHIF) today announced its first implant of the world’s smallest pacemaker: the Medtronic Micra Transcatheter Pacing System (TPS) in the Midwest. The device was implanted by Dr. Charles Gornick...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading